Innovent Biologics Inc.

OTC: IVBXF · Real-Time Price · USD
12.70
0.46 (3.76%)
At close: Aug 21, 2025, 3:46 PM
12.70
0.00%
After-hours: Aug 21, 2025, 04:00 PM EDT

Innovent Biologics Cash Flow Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-78.62M -1.14B -2.17B -3.05B
Depreciation & Amortization
n/a 385.1M 319.42M 204.75M
Stock-Based Compensation
556.52M 574.2M 469.49M 501.57M
Other Working Capital
n/a 475.07M -29.63M 551.3M
Other Non-Cash Items
-14.4M -70.47M -847.15M -49.55M
Deferred Income Tax
n/a n/a n/a 50.38M
Change in Working Capital
n/a 403.39M 309.91M -90.28M
Operating Cash Flow
n/a 147.81M -1.92B -2.02B
Capital Expenditures
n/a -1.38B -1.38B -1.85B
Cash Acquisitions
n/a n/a n/a -630.14M
Purchase of Investments
n/a -9.41B -10.33B -10.34B
Sales Maturities Of Investments
n/a 9.24B 10.02B 10.12B
Other Investing Acitivies
n/a 290.87M 252.4M -4.08M
Investing Cash Flow
n/a -998.66M -1.44B -2.7B
Debt Repayment
n/a 418.5M 715.17M 1.21B
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -86.36M 45.85M -155.24M
Financial Cash Flow
n/a 2.59B 2.89B 5B
Net Cash Flow
-472.34M 1.73B -343.24M 83.23M
Free Cash Flow
n/a -1.24B -3.3B -3.87B